Important Form D Filing: Sqz Biotechnologies Co $24.06 million Financing. Armon Sharei PhD Filed Dec 1 SEC Form

Biotechnology Sqz Biotechnologies Co - Armon Sharei PhD

Sqz Biotechnologies Co Financing

Sqz Biotechnologies Co, Corporation just filed form D for $24.06 million equity financing. The date of first sale was 2016-09-19. Sqz Biotechnologies Co was able to finance itself with $24.06 million. That is 100.00% of the financing round. The total fundraising amount was $24.06 million. The financing form was filed on 2016-12-01. The reason for the financing was: unspecified.

Sqz Biotechnologies Co is based in Massachusetts. The company’s business is Biotechnology. The D form was submitted by Armon Sharei PhD Chief Executive Officer. The company was incorporated in 2013. The filler’s address is: 134 Coolidge Avenue, Watertown, Ma, Massachusetts, 02472. Armon Sharei, Ph.D. is the related person in the form and it has address: 134 Coolidge Avenue, Watertown, Ma, Massachusetts, 02472. Link to Sqz Biotechnologies Co Filing: 000160447716000002.

Analysis of Sqz Biotechnologies Co Offering

On average, startups in the Biotechnology sector, sell 73.77% of the total offering amount. Sqz Biotechnologies Co sold 100.00% of the offering. Could this mean that the trust in Sqz Biotechnologies Co is high? The average investment floor size for companies in the Biotechnology industry is $3.08 million. The total amount raised is 681.23% bigger than the average for companies in the Biotechnology sector. The minimum investment for this fundraising is set at $0. If you know more about the reasons for the fundraising, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Sqz Biotechnologies Co Also

The Form D signed by Armon Sharei PhD might help Sqz Biotechnologies Co’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment